OFFICERS Dan    Terry,    Briotech    Founder,    CEO    &    CTO:    Dan   Terry   is   an   inventor   and   the   founder   of   Briotech,   Inc. With   30+   years   of   experience   in   design-for-manufacturability   of   electro-mechanical   and   mechanical devices,    Dan    specializes    in    product    and    component    development,    start-up,    ramp-up,    continuous improvement     and     supply     chain     management.     He     provides     solutions     in     design,     manufacturing processes,   supplier   selection   and   management,   and   component   supply.   Dan’s   specialties   include   'change   agent' review,    LED    thermal    solutions,    thermal    products,    alternative    energy    in    micropower,    hydro-power,    ethanol distillation,    solar,    clean    coal,    hydrogen,    IP    review    and    IP    development.    After    four    years    in    development    at Danterry,   Inc. ,   Briotech,   Inc.   was   spun   out   as   a   manufacturer   of   stable,   ultra-pure   Hypochlorous   Acid   (HOCl)   for biocide   products,   the   cosmetics   industry,   animal   and   human   healthcare,   hospital   disinfection,   pathogen   control, and    the    agriculture    industries.    Briotech’s    patent-pending    innovations    include    new    electrolysis    technology, development   of   mobile   HOCl   factory   systems    for   disaster   relief   and   pathogen   disinfection   spray   and   fogging systems.  linkedin.com/pub/dan-terry Cynthia   Varela,   Briotech   Founder   and   Chief   Administrative   Officer:    Cynthia   Varela   is   the   founder   of Briotech,   Inc.      She   has   worked   alongside   Dan   Terry   for   the   past   26   years,   running   Danterry,   Inc.   and   in the    start-up    of    Briotech.    She    has    over    32    years    of    experience    in    administrative    and    business management   operations.      Her   structured   and   supportive   nature   coupled   with   her   enthusiastic   and entrepreneurial    spirit,    have    proven    key    success    throughout    her    career    and    in    running    her    own    companies. Cynthia   carries   with   her   a   keen   sense   of   company   vision   for   Briotech,   and   specializes   in   strategic   and   thoughtful carry-through of that vision through customer service. cindi@briotechusa.com Jeff   Williams,   PhD,   BVSc,   MRCVS,   Briotech   Chief   Science   Officer:    Dr.   Williams   had   a   long   career                    in    academic    microbiology    and    infectious    diseases,    retiring    after    27    years    from    his    position    as      Professor   Emeritus   of   Microbiology   and   Molecular   Genetics,   Michigan   State   University   to   found   a biotechnology    start-up,    HaloSource,    Inc.,    in    Seattle,    WA    in    1998.    Retiring    again    in    2014,    he    has remained    active    as    technical    advisor    to    several    companies    in    the    PNW    region,    specializing    in    the    areas    of antimicrobial   chemistry   and   disinfection.   Author   of   over   200   scientific   papers   and   textbook   chapters,   he   served four   years   as   a   member   of   the   Board   of   Counselors   to   the   US-NIH   Institute   of   Allergy   and   Infectious   Diseases, and   has   been   a   frequent   consultant   to   the   World   Health   Organisation   of   the   UN   in   Geneva,   Switzerland.   Jeff   was elected   Fellow   of   the   American   Association   for   the   Advancement   of   Science   (AAAS)   in   1996,   and   served   as retained    consultant    to    first    Merck,    Inc.    (1980-1982),    then    Pharmacia    (now    Pfizer,    Inc.)    (1983-1999)    on therapeutic   drug   discovery   and   development.   He   has   a   long   standing   interest   in   tropical   infectious   diseases, starting   with   his   appointment   as   staff   scientist   for   WHO   in   Argentina   1968-71,   and   for   15   years   directed   a collaborative   NIH-funded   Program   Project   on   Infectious   Diseases   in   Sudan.   He   holds   degrees   in   Veterinary Science    (BVSc)    from    the    University    of    Bristol,    UK    (1964),    and    Pathobiology    (PhD)    from    the    University    of Pennsylvania (1968), where he was a Fulbright Scholar (1964-1968).  linkedin.com/pub/jeff-williams Eric   Rasmussen,   MD,   MDM,   FACP,   Briotech   Chief   Medical   Officer:       Dr.   Rasmussen   is   a   global         expert, consultant   and   teacher   in   disaster   medicine   and   response   technologies   in   the   US,   China,   and   Germany. He   has   25   years   of   experience   as   a   Navy   physician   with   multiple   combat   tours   in   Bosnia,   Iraq   and Afghanistan,    and    more    conventional    medical    experience    as    an    Intensive    Care    Unit    Director    and Chairman   of   an   academic   Department   of   Medicine.   He   spent   nine   years   as   a   Principal   Investigator with   the   Defense   Advanced   Research   Projects   Agency   (DARPA)   and   is   now   the   CEO   of   Infinitum   Humanitarian Systems,    a    humanitarian    sciences    consulting    group    with    projects    in    Mexico,    Tanzania,    Latvia,    Nepal,    the Philippines,    and    China.    He    also    leads    the    global    disaster    response    team    for    the    Roddenberry    Foundation, supported by the “Star Trek” franchise, and holds multiple academic, advisory, and public service appointments.                                                            linkedin.com/in/ericrasmussenmd Kevin     Mayo,     CPA,     MBA,     Briotech     Chief     Financial     Officer:         Kevin    Mayo    received    his    Bachelor    of Business   Administration   degree   in   Accounting   from   the   University   of   Notre   Dame   followed   by   his   CPA. He   also   holds   an   MBA   from   the   University   of   Tulsa.   Kevin   is   a   strategic   developer,   dynamic   relationship builder   and   a   collaborative   leader   with   25   plus   years   of   management   experience   in   accounting   and finance.    He    has    worked    in    a    variety    of    industries    including    public    accounting,    consumer    products,    heavy equipment   and   consulting.   Kevin   began   his   career   working   for   Ernst   &   Young   where   he   worked   with   many   types of   clients   including   financial,   consumer   products,   nonprofit   and   small   business.   Following   his   public   accounting experience,   he   worked   his   way   up   management   in   several   companies   including   Brunswick   Corporation,   Kraft Foods,   Gear   Products   and   Blythe   Industries.   Kevin   then   joined   the   ranks   of   senior   management   at   Terex   Mining where   he   served   as   the   Division   Controller   for   a   $300   million   revenue   global   manufacturer   of   mining   trucks   and shovels.   Next   Kevin   moved   to   Terex   Aerial   Work   Platforms   (Genie   Industries),   as   the   Division   Controller   for   a $2.3    billion    global    manufacturer    of    aerial    work    platforms.    After    working    for    Genie    Industries    in    Redmond, Washington   Kevin   moved   to   Shanghai,   China   for   3   ½   years   and   Brisbane,   Australia   for   1   ½   years.   In   Asia   Pacific, he    was    able    to    engage    his    strategic    development    skills    as    a    key    member    of    a    team    that    developed    a manufacturing plant in China. linkedin.com/in/kevinamayo ADVISORS
Bryan   Hurd,   CISSP,   CISA,   CISM,   CCCI,   CCFT:       Bryan   is   the   Director   of   Advanced   Analytics   Cybercrime   Center at   Microsoft.   Bryan   is   a   global   expert   in   strategic   response   to   terrorism,   cybercrime   and   cyber   security   with   20+ years   of   experience   in   military,   government   civilian   and   commercial   corporation   roles.   He   founded   the   first   cyber counterintelligence   program   for   the   US   Navy,   was   in   charge   of   innovation   and   national   data   integration   for   US watchlisting and was the first director of intelligence for Microsoft’s global cybercrime center.                                                 linkedin.com/in/bryanhurd
Caitlin    Cameron:     Caitlin    is    the    Chairman    and    CEO    of    OtoNexus    Medical    Technologies.    She    is    a    highly- accomplished   senior   executive   with   30   years   cross-industry   expertise   in   the   Life   Sciences,   Biotech   Technology, and    IT    industries.    She    is    a    specialist    in    building    successful    start-up    companies    and    taking    them    through    to successful   exit.   Previously,   she   held   Chair   and   CEO   positions   at   several   Life   Sciences   and   IT   companies,   building successful businesses and organizations, creating value and maximizing potential in a very short period of time. linkedin.com/in/caitlincameron
CONTACT THE BRIOTECH TEAM
BRIOTECH, ITS LOGOS, LANGUAGE, AND IMAGES ARE TRADEMARKS AND/OR THE COPYRIGHT PROPERTY OF BRIOTECH, INC. AND/OR ITS AFFILIATES. © 2013-2017
BRIOTECH, ITS LOGOS, LANGUAGE, AND IMAGES ARE TRADEMARKS AND/OR THE COPYRIGHT PROPERTY OF BRIOTECH, INC. AND/OR ITS AFFILIATES. © 2013-2017
Jeremy   Stone:    Jeremy   is   a   physician,   entrepreneur   and   financier,   with   international   interests   in   life   sciences, aviation,   transport,   structured   finance,   healthcare   reform   and   strategy.   Trained   in   the   British   National   Health Service,   he   has   worked   globally   as   investor,   Chair,   CFO,   CEO   and   COO,   yet   inside   remains   a   physician   with   a passion for disruptive life-enhancing innovation.                             linkedin.com/in/jeremyornanstone 
FDA FACILITY REG #3012261723 | EPA #93108
CONTACT THE BRIOTECH TEAM
OFFICERS Dan   Terry,   Briotech   Founder,   CEO   &   CTO:    Dan Terry   is   an   inventor   and   the   founder   of   Briotech, Inc.   With   30+   years   of   experience   in   design-for- manufacturability     of     electro-mechanical     and     mechanical devices,      Dan      specializes      in      product      and      component development,    start-up,    ramp-up,    continuous    improvement and    supply    chain    management.    He    provides    solutions    in design,     manufacturing     processes,     supplier     selection     and management,      and      component      supply.      Dan’s      specialties include     'change     agent'     review,     LED     thermal     solutions, thermal   products,   alternative   energy   in   micropower,   hydro- power,    ethanol    distillation,    solar,    clean    coal,    hydrogen,    IP review   and   IP   development.   After   four   years   in   development at      Danterry,      Inc. ,      Briotech,      Inc.      was      spun      out      as      a manufacturer      of      stable,      ultra-pure      Hypochlorous      Acid (HOCl)   for   biocide   products,   the   cosmetics   industry,   animal and      human      healthcare,      hospital      disinfection,      pathogen control,    and    the    agriculture        industries.    Briotech’s    patent- pending    innovations    include    new    electrolysis    technology, development    of    mobile    HOCl    factory    systems     for    disaster relief and pathogen disinfection spray and fogging systems.  linkedin.com/pub/dan-terry Cynthia     Varela,     Briotech     Founder     and     Chief Administrative     Officer:      Cynthia     Varela     is     the founder      of      Briotech,      Inc.      She      has      worked alongside   Dan   Terry   for   the   past   26   years,   running   Danterry, Inc.   and   in   the   start-up   of   Briotech.   She   has   over   32   years   of experience     in     administrative     and     business     management operations.    Her    structured    and    supportive    nature    coupled with   her   enthusiastic   and   entrepreneurial   spirit,   have   proven key   success   throughout   her   career   and   in   running   her   own companies.   Cynthia   carries   with   her   a   keen   sense   of   company vision      for      Briotech,      and      specializes      in      strategic      and thoughtful    carry-through    of    that    vision    through    customer service. cindi@briotechusa.com Jeff     Williams,     PhD,     BVSc,     MRCVS,     Briotech Chief    Science    Officer:     Dr.    Williams    had    a    long career    in    academic    microbiology    and    infectious diseases,     retiring     after     27     years     from     his     position     as Professor   Emeritus   of   Microbiology   and   Molecular   Genetics, Michigan   State   University   to   found   a   biotechnology   start-up, HaloSource,    Inc.,    in    Seattle,    WA    in    1998.    Retiring    again    in 2014,   he   has   remained   active   as   technical   advisor   to   several companies    in    the    PNW    region,    specializing    in    the    areas    of antimicrobial   chemistry   and   disinfection.   Author   of   over   200 scientific   papers   and   textbook   chapters,   he   served   four   years as    a    member    of    the    Board    of    Counselors    to    the    US-NIH Institute   of   Allergy   and   Infectious   Diseases,   and   has   been   a frequent   consultant   to   the   World   Health   Organisation   of   the UN   in   Geneva,   Switzerland.   Jeff   was   elected   Fellow   of   the American     Association     for     the     Advancement     of     Science (AAAS)   in   1996,   and   served   as   retained   consultant   to   first Merck,    Inc.    (1980-82),    then    Pharmacia    (now    Pfizer,    Inc.) (1983-99)   on   therapeutic   drug   discovery   and   development. He   has   a   long   standing   interest   in   tropical   infectious   diseases, starting   with   his   appointment   as   staff   scientist   for   WHO   in Argentina   1968-71,   and   for   15   years   directed   a   collaborative NIH-funded     Program     Project     on     Infectious     Diseases     in Sudan.   He   holds   degrees   in   Veterinary   Science   (B.V.Sc.)   from the   University   of   Bristol,   UK   (1964),   and   Pathobiology   (Ph.D) from   the   University   of   Pennsylvania   (1968),   where   he   was   a Fulbright Scholar (1964-68).  linkedin.com/pub/jeff-williams Eric     Rasmussen,     MD,     MDM,     FACP,     Briotech Chief   Medical   Officer:    Dr.   Rasmussen   is   a   global expert,      consultant      and      teacher      in      disaster medicine    and    response    technologies    in    the    US,    China,    and Germany.   He   has   25   years   of   experience   as   a   Navy   physician with   multiple   combat   tours   in   Bosnia,   Iraq   and   Afghanistan, and    more    conventional    medical    experience    as    an    Intensive Care      Unit      Director      and      Chairman      of      an      academic Department   of   Medicine.   He   spent   nine   years   as   a   Principal Investigator   with   the   Defense   Advanced   Research   Projects Agency      (DARPA)      and      is      now      the      CEO      of      Infinitum Humanitarian    Systems,    a    humanitarian    sciences    consulting group   with   projects   in   Mexico,   Tanzania,   Latvia,   Nepal,   the Philippines,    and    China.    He    also    leads    the    global    disaster response   team   for   the   Roddenberry   Foundation,   supported by    the    “Star    Trek”    franchise,    and    holds    multiple    academic, advisory, and public service appointments.                                                            linkedin.com/in/ericrasmussenmd Kevin   Mayo,   CPA,   MBA,   Briotech   Chief   Financial Officer:     Kevin    Mayo    received    his    Bachelor    of Business     Administration     degree     in     Accounting from   the   University   of   Notre   Dame   followed   by   his   CPA.   He also   holds   an   MBA   from   the   University   of   Tulsa.   Kevin   is   a strategic     developer,     dynamic     relationship     builder     and     a collaborative     leader     with     25     plus     years     of     management experience    in    accounting    and    finance.    He    has    worked    in    a variety   of   industries   including   public   accounting,   consumer products,   heavy   equipment   and   consulting.   Kevin   began   his career    working    for    Ernst    &    Young    where    he    worked    with many   types   of   clients   including   financial,   consumer   products, nonprofit   and   small   business.   Following   his   public   accounting experience,    he    worked    his    way    up    management    in    several companies    including    Brunswick    Corporation,    Kraft    Foods, Gear   Products   and   Blythe   Industries.   Kevin   then   joined   the ranks    of    senior    management    at    Terex    Mining    where    he served   as   the   Division   Controller   for   a   $300   million   revenue global   manufacturer   of   mining   trucks   and   shovels.   Next   Kevin moved   to   Terex   Aerial   Work   Platforms   (Genie   Industries),   as the   Division   Controller   for   a   $2.3   billion   global   manufacturer of   aerial   work   platforms.   After   working   for   Genie   Industries in    Redmond,    Washington    Kevin    moved    to    Shanghai,    China for   3   ½   years   and   Brisbane,   Australia   for   1   ½   years.   In   Asia Pacific,   he   was   able   to   engage   his   strategic   development   skills as   a   key   member   of   a   team   that   developed   a   manufacturing plant in China. linkedin.com/in/kevinamayo ADVISORS
Bryan   Hurd,   CISSP,   CISA,   CISM,   CCCI,   CCFT:    Bryan   is   the   Director   of Advanced   Analytics   Cybercrime   Center   at   Microsoft.   Bryan   is   a   global expert   in   strategic   response   to   terrorism,   cybercrime   and   cyber   security with    20+    years    of    experience    in    military,    government    civilian    and commercial       corporation       roles.       He       founded       the       first       cyber counterintelligence     program     for     the     US     Navy,     was     in     charge     of innovation   and   national   data   integration   for   US   watchlisting   and   was   the first director of intelligence for Microsoft’s global cybercrime center.                                                linkedin.com/in/bryanhurd
Caitlin     Cameron:      Caitlin     is     the     Chairman     and     CEO     of     OtoNexus Medical    Technologies.    She    is    a    highly-accomplished    senior    executive with    30    years    cross-industry    expertise    in    the    Life    Sciences,    Biotech Technology,   and   IT   industries.   She   is   a   specialist   in   building   successful start-up     companies     and     taking     them     through     to     successful     exit. Previously,   she   held   Chair   and   CEO   positions   at   several   Life   Sciences and    IT    companies,    building    successful    businesses    and    organizations, creating value and maximizing potential in a very short period of time. linkedin.com/in/caitlincameron
BRIOTECH, ITS LOGOS, LANGUAGE, AND IMAGES ARE TRADEMARKS AND/OR THE COPYRIGHT PROPERTY OF BRIOTECH, INC. AND/OR ITS AFFILIATES. © 2013-2017
BRIOTECH, ITS LOGOS, LANGUAGE & IMAGES ARE TRADEMARKS & COPYRIGHT PROPERTY OF BRIOTECH, INC. & ITS AFFILIATES. © 2013-2017
Jeremy   Stone:    Jeremy   is   a   physician,   entrepreneur   and   financier,   with international    interests    in    life    sciences,    aviation,    transport,    structured finance,   healthcare   reform   and   strategy.   Trained   in   the   British   National Health   Service,   he   has   worked   globally   as   investor,   Chair,   CFO,   CEO   and COO,   yet   inside   remains   a   physician   with   a   passion   for   disruptive   life- enhancing innovation.                             linkedin.com/in/jeremyornanstone 
FDA FACILITY REG #3012261723 | EPA #93108